2017
DOI: 10.1159/000484348
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence

Abstract: Subjects with schizophrenia (SZ) and bipolar disorder (BD) show decreased protein and transcript levels for mitochondrial complex I. In vitro results suggest antipsychotic and antidepressant drugs may be responsible. We measured complex I activity in BD, SZ, and controls and presence of antipsychotic and antidepressant medications, mitochondrial DNA (mtDNA) copy number, and the mtDNA “common deletion” in the brain. Complex I activity in the prefrontal cortex was decreased by 45% in SZ compared to controls (p =… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
38
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(42 citation statements)
references
References 49 publications
3
38
0
1
Order By: Relevance
“…Less is known about changes in the mitochondrial electron transport system in acute psychosis and schizophrenia, but especially prominent among pathogenically-related decreased levels of DNA and transcriptional activity in schizophrenia are decreases in complex I genes, proteins and activities 21 , 22 . The significant decreases in levels of complex I protein in brain tissues of schizophrenic patients have been attributed partially to medications 23 . Nonetheless, induced pluripotent stem cell (iPSC) lines of interneurons from schizophrenic patients showed altered expression of genes encoding proteins involved in numerous mitochondrial activities, including increased generation of ROS 24 .…”
Section: Discussionmentioning
confidence: 99%
“…Less is known about changes in the mitochondrial electron transport system in acute psychosis and schizophrenia, but especially prominent among pathogenically-related decreased levels of DNA and transcriptional activity in schizophrenia are decreases in complex I genes, proteins and activities 21 , 22 . The significant decreases in levels of complex I protein in brain tissues of schizophrenic patients have been attributed partially to medications 23 . Nonetheless, induced pluripotent stem cell (iPSC) lines of interneurons from schizophrenic patients showed altered expression of genes encoding proteins involved in numerous mitochondrial activities, including increased generation of ROS 24 .…”
Section: Discussionmentioning
confidence: 99%
“…However, the study was limited by a small sample size (18 subjects); the young ages of the subjects, who were minimally exposed to medication; and the recent onset of BD. No differences in complex I activity were found postmortem in prefrontal cortex mitochondria from BD and controls 19. The activity of other complexes or mitochondrial respiration has not been determined.…”
Section: Introductionmentioning
confidence: 85%
“…The activity of other complexes or mitochondrial respiration has not been determined. High complex I activity was found in patients without medication; decreased complex I activity was found in patients with detectable psychotropic medications 19…”
Section: Introductionmentioning
confidence: 95%
“…Together with the activity of Complex I, NDUFB9 has been investigated in other brain areas in SZ [59,60]. Thus, the altered expression of NDUFB9 observed in this study could contribute to reduce energy metabolism in cerebellar cells through the disruption of Complex I in respiratory electron transport and could consequently decrease the propagation action potentials among the major cell types of the cerebellar cortex in chronic SZ.…”
Section: Energy Metabolism Modulementioning
confidence: 68%